MIT Technology Review·2026-10-30 17:00· 4 d agoFeaturedRecommendation90.80

Eating disorders are on the rise. GLP-1s could make things worse.

Reading guide

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…

Plus

The full article is a Plus feature

A free account reads ten library articles a day, a fresh ten each day, and those ten open in full — body, vocabulary and PDF export. Plus opens everything below.

· Every library article, no limit
· PDF export for everything you can read
· Daily, weekly and monthly issues, plus the daily email
· Classics, publications and topics

¥9.9 / month

See Plus Already have an account? Sign in

Source:MIT Technology Review · technologyreview.com

#Health & medicine #Data & statistics #Social change #Cause & effect #Public policy